Skip to main content
. Author manuscript; available in PMC: 2015 Jun 13.
Published in final edited form as: J Clin Oncol. 2008 Jul 20;26(21):3598–3606. doi: 10.1200/JCO.2008.16.1323

Fig 1.

Fig 1

Kaplan-Meier estimates of (A, C) progression-free survival (PFS) and (B, D) overall survival (OS) in the entire cohort categorized by polymorphisms in (A, B) codon 118 and (C, D) C8092A in the ERCC1 gene. Censored indicates women who were alive with no evidence of disease progression at last contact, and event reflects women with documented recurrence/disease progression or death.